Nerve growth factor therapy for corneal disease

Alessandro Lambiase1, Marta Sacchetti, Stefano Bonini

  • 1Department of Ophthalmology, University of Rome Campus Bio-Medico, Via Alvarodel Portillo 200, Rome, Italy. a.lambiase@unicampus.it

Summary

Nerve growth factor (NGF) demonstrates significant therapeutic potential for various corneal diseases by supporting ocular surface healing and modulating immune responses. Future development of NGF therapy promises new treatments for infective and noninfective ocular surface conditions.